Biotechnology
Ocular Therapeutix Announces Private Placement to Bolster Clinical Development Initiatives
Ocular Therapeutix, Inc. (OCUL), a pioneering biopharmaceutical company dedicated to advancing vision-related therapies, has disclosed its strategic move to enhance...
Monopar’s MNPR-101 Radiopharma Program Shows Promise in Targeting Advanced Cancers
Monopar Therapeutics (MNPR) has unveiled promising preclinical data for its MNPR-101 radiopharmaceutical program, marking a significant stride in the fight...
Moderna Reports Strong Spikevax Sales and Expands Vaccine Portfolio
Moderna Inc (MRNA) witnessed a surge in its stock following its fourth-quarter 2023 financial report, which showcased robust revenues of...
Bausch + Lomb’s Strong Growth Outlook Boosts Stock Amid Losses
Bausch + Lomb Corp (BLCO) experienced a significant surge in its stock value, rising by 15.8%, despite facing deeper losses,...
Dr. Alessandra Cesano Joins Zymeworks Board of Directors
Zymeworks Inc. (Nasdaq: ZYME) has appointed Dr. Alessandra Cesano to its board of directors, effective February 8, 2024, succeeding Dr....
I-Mab Shifts Focus; Divests Chinese Operations to Propel U.S. Biotech Ambitions
In a strategic move to bolster its presence in the U.S. biotech landscape, I-Mab (NASDAQ: IMAB), a renowned global biotech...
